Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer

BACKGROUND: To improve the efficacy of first-line therapy for advanced non-small cell lung cancer (NSCLC), additional maintenance chemotherapy may be given after initial induction chemotherapy in patients who did not progress during the initial treatment, rather than waiting for disease progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Paz-Ares, Luis G, Altug, Sedat, Vaury, Alexandra Thareau, Jaime, Jesús Corral, Russo, Francesca, Visseren-Grul, Carla
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847958/
https://www.ncbi.nlm.nih.gov/pubmed/20211022
http://dx.doi.org/10.1186/1471-2407-10-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847958/
https://www.ncbi.nlm.nih.gov/pubmed/20211022
http://dx.doi.org/10.1186/1471-2407-10-85

Ejemplares similares